UBS Group
SGAR

UBS Group’s iPath Pure Beta Sugar ETN SGAR Stock Holding History

UBS Group’s Portfolio SGAR Stock Details SGAR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q2 		– Sell
-1,442
Closed -$28K – 8606
2018
Q1 		$28K Hold
1,442
– – ﹤0.01% 6169
2017
Q4 		$33K Sell
1,442
-100
-6% -$2.27K ﹤0.01% 6175
2017
Q3 		$34K Sell
1,542
-9
-0.6% -$207 ﹤0.01% 6089
2017
Q2 		$35K Buy
1,551
+263
+20% +$6.38K ﹤0.01% 5920
2017
Q1 		$29K Sell
1,288
-7
-0.5% -$227 ﹤0.01% 5898
2016
Q4 		$40K Buy
1,295
+994
+330% +$32.7K ﹤0.01% 6009
2016
Q3 		$11K Sell
301
-1,105
-79% -$35.9K ﹤0.01% 6752
2016
Q2 		$45K Sell
1,406
-738
-34% -$20.4K ﹤0.01% 5606
2016
Q1 		$53K Buy
2,144
+819
+62% +$18.9K ﹤0.01% 5470
2015
Q4 		$31K Sell
1,325
-1,662
-56% -$37.2K ﹤0.01% 6311
2015
Q3 		$58K Buy
2,987
+2,610
+692% +$49.7K ﹤0.01% 5705
2015
Q2 		$8K Buy
+377
New +$8.14K ﹤0.01% 7642

UBS Group's SGAR Position: Q2 2018 in Review

UBS Group sold out of iPath Pure Beta Sugar ETN (SGAR) in Q2 2018, closing a stake of 1,442 shares — an estimated $28K sold.

UBS Group first reported a position in SGAR in Q2 2015 and held it in 12 quarters. The position peaked at $58K in Q3 2015. 0 funds tracked by Wall St. Rank hold SGAR as of Q2 2018.

  • UBS Group reported no remaining iPath Pure Beta Sugar ETN position as of Q2 2018 after selling out during the quarter.
  • UBS Group sold 1,442 iPath Pure Beta Sugar ETN shares in Q2 2018, an estimated $28K.
  • UBS Group first reported a position in iPath Pure Beta Sugar ETN in Q2 2015 and held it in 12 quarters.
  • UBS Group's iPath Pure Beta Sugar ETN position peaked at $58K in Q3 2015.
  • 0 funds tracked by Wall St. Rank held iPath Pure Beta Sugar ETN as of Q2 2018.

Based on UBS Group's 13F filing for Q2 2018, filed 14 Aug 2018.